Brr Op Co, LLC Repligen Corp Transaction History

Brr Op Co, LLC

$815 Million
Q3 2022

A detailed history of Brr Op Co, LLC transactions in Repligen Corp stock. As of the latest transaction made, Brr Op Co, LLC holds 2,000 shares of RGEN stock, worth $288,920. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,000

Previous 2,000 -0.0%

Holding current value

$288,920

Previous $325,000 15.08%

% of portfolio

0.05%

Previous 0.04%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$140.68 - $188.02 $28,136 - $37,604	-200 Reduced 9.09%	2,000 $325,000
Q1 2022 May 05, 2022	BUY	$161.19 - $257.96 $32,238 - $51,591	200 Added 10.0%	2,200 $414,000
Q3 2021 Nov 05, 2021	SELL	$194.77 - $324.21 $48,692 - $81,052	-250 Reduced 11.11%	2,000 $578,000
Q1 2021 May 12, 2021	SELL	$180.37 - $226.26 $135,277 - $169,695	-750 Reduced 25.0%	2,250 $437,000
Q4 2020 Feb 10, 2021	SELL	$148.08 - $206.57 $59,232 - $82,628	-400 Reduced 11.76%	3,000 $575,000
Q2 2020 Aug 13, 2020	SELL	$94.33 - $140.48 $94,330 - $140,480	-1,000 Reduced 22.73%	3,400 $420,000
Q1 2020 May 07, 2020	BUY	$84.96 - $109.14 $67,968 - $87,312	800 Added 22.22%	4,400 $425,000
Q3 2019 Nov 12, 2019	SELL	$76.65 - $95.51 $4,292 - $5,348	-56 Reduced 1.53%	3,600 $276,000
Q2 2019 Aug 14, 2019	SELL	$54.2 - $85.95 $78,264 - $124,111	-1,444 Reduced 28.31%	3,656 $314,000
Q4 2018 Feb 14, 2019	SELL	$48.26 - $68.88 $48,260 - $68,880	-1,000 Reduced 16.39%	5,100 $269,000
Q1 2018 May 11, 2018	BUY	$30.92 - $37.27 $188,612 - $227,347	6,100 New	6,100 $220,000

Others Institutions Holding RGEN

# of Institutions

488

Shares Held

54.2M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brr Op Co, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brr Op Co, LLC with notifications on news.

Account